Abstract:This paper builds on the context and recent progress on the control, reproducibility, and limitations of using graphene and graphene-related materials (GRMs) in biomedical applications. The review describes the human hazard assessment of GRMs in in vitro and in vivo studies, highlights the composition–structure–activity relationships that cause toxicity for these substances, and identifies the key parameters that determine the activation of their biological effects. GRMs are designed to offer the advantage of facilitating unique biomedical applications that impact different techniques in medicine, especially in neuroscience. Due to the increasing utilization of GRMs, there is a need to comprehensively assess the potential impact of these materials on human health. Various outcomes associated with GRMs, including biocompatibility, biodegradability, beneficial effects on cell proliferation, differentiation rates, apoptosis, necrosis, autophagy, oxidative stress, physical destruction, DNA damage, and inflammatory responses, have led to an increasing interest in these regenerative nanostructured materials. Considering the existence of graphene-related nanomaterials with different physicochemical properties, the materials are expected to exhibit unique modes of interactions with biomolecules, cells, and tissues depending on their size, chemical composition, and hydrophil-to-hydrophobe ratio. Understanding such interactions is crucial from two perspectives, namely, from the perspectives of their toxicity and biological uses. The main aim of this study is to assess and tune the diverse properties that must be considered when planning biomedical applications. These properties include flexibility, transparency, surface chemistry (hydrophil–hydrophobe ratio), thermoelectrical conductibility, loading and release capacity, and biocompatibility.

Impact of the Graphene Production Methods Sonication and Microfluidization on In Vitro and In Vivo Toxicity, Macrophage Response, and Complement Activation

Graphene for the development of the next-generation of biocomposites for dental and medical applications

Cytotoxicity of Graphene: Recent Advances and Future Perspective.

Graphene Nanomaterials: Synthesis, Biocompatibility, and Cytotoxicity

Assessing in Vivo Toxicity of Graphene Materials: Current Methods and Future Outlook

Biocompatibility of Pristine Graphene Monolayers, Nanosheets and Thin Films

Impact of Ultrasonic Probe Type, Frequency, and Static Pressure on Large-Scale Graphene Exfoliation

Nanotoxicity of Graphene and Graphene Oxide

In Vitro Toxicity Evaluation of Graphene Oxide on A549 Cells.

Progress in Biological Safety of Graphene

Toxicology Data of Graphene-Family Nanomaterials: an Update

Graphene-Related Nanomaterials for Biomedical Applications

Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols

Toxicity of Graphene-Family Nanoparticles: a General Review of the Origins and Mechanisms

Characterization and Toxicological Effects of Three-Dimensional Graphene Foams in Rats in Vivo

The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-κB-related signaling pathways.

Biotransformation and biological impact of graphene and graphene oxide during simulated oral ingestion

Bacterial Surface Disturbances Affecting Cell Function during Exposure to Three-Compound Nanocomposites Based on Graphene Materials

Graphene-based nanomaterials: biological and medical applications and toxicity

Graphene: a versatile nanoplatform for biomedical applications.

The Neurotoxic Mechanisms of Graphene Family Nanomaterials at the Cellular Level: A Solution-based Approach Review